ストックスクリーナーアプリを入手
7.595
6.70%
-0.545
アフターアワーズ：
7.60
0.005
+0.07%
Exozymes Inc (EXOZ) 最新ニュース
If You Invested $1,000 in Invizyne Technologies Inc (IZTC) - Stock Titan
Enterprise value to revenue forward of eXoZymes Inc. – NASDAQ:EXOZ - TradingView
Price to earnings forward of eXoZymes Inc. – NASDAQ:EXOZ - TradingView
eXoZymes Completes New Securities Offering to Fund Pipeline - TipRanks
eXoZymes Raises $0.64 Million Via Unit Offering; Adds MDB Placement Pact and Warrant Coverage - TradingView
eXoZymes (NASDAQ: EXOZ) raises $639K in unit sale with resettable warrants - Stock Titan
Form 424B5 eXoZymes Inc For: 30 June - Investing.com UK
Form 424B5 eXoZymes Inc For: 30 June By Investing.com - Investing.com Canada
eXoZymes (EXOZ) raises net $565K; warrants exercisable 6/5/2027–2031 - Stock Titan
eXoZymes Inc (EXOZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
eXoZymes Secures $2M NIH Grant to Advance AI-Engineered Cannabinoid Analogs for Drug Discovery - Minichart
eXoZymes Secures NIH Grant to Advance Cannabinoid Pipeline - TipRanks
eXoZymes awarded $2.03M NIH SBIR grant to develop cannabinoid analogs - TradingView
eXoZymes (NASDAQ: EXOZ) lands $2,028,518 NIH grant for cannabinoid analog R&D - Stock Titan
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery - The National Law Review
eXoZymes Inc (EXOZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
exoZymes receives $2M NIH grant for cannabinoid research - Investing.com
EXoZymes receives $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery - marketscreener.com
eXoZymes stock rises on $2M NIH grant for cannabinoid work - Investing.com South Africa
eXoZymes stock rises on $2M NIH grant for cannabinoid work By Investing.com - Investing.com Australia
NIH backs eXoZymes' cannabinoid drug discovery work with $2M grant - Stock Titan
eXoZymes Inc (EXOZ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
eXoZymes Inc (EXOZ) Institutional Confidence - TradingKey
eXoZymes Inc (EXOZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
eXoZymes Inc (EXOZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
eXoZymes Inc (EXOZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
eXoZymes Inc (EXOZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
eXoZymes closes $5.95M public offering of stock and warrants By Investing.com - Investing.com Australia
eXoZymes Inc (EXOZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
eXoZymes Completes Nasdaq Equity Offering to Fund Pipeline - TipRanks
Exozymes Raises $5.95 Million in Underwritten Equity Offering Led by MDB Capital - TradingView
eXoZymes (NASDAQ: EXOZ) closes $5.95M stock and warrant unit offering - Stock Titan
eXoZymes closes $5.95M public offering of stock and warrants - Investing.com
eXoZymes Inc. Announces Closing of $6 Million Public Offering - Newswire.com
eXoZymes closes $5.95 million public offering to fund development - scanx.trade
eXoZymes Inc. (EXOZ) Rises 3.3% as Biotech Momentum Builds, Testing Key Resistance at $7.97Continuation Pattern Picks - newsline.com
eXoZymes (EXOZ) Prices Public Offering of Units - GuruFocus
eXoZymes Announces Public Equity Offering to Fund Growth - TipRanks
eXoZymes Prices $18 Unit Equity Offering; MDB Capital Underwrites $5.33 Million Deal - TradingView
eXoZymes (NASDAQ: EXOZ) sells units in $5.3M underwritten offering - Stock Titan
eXoZymes prices $5.33M offering of units at $18/unit - scanx.trade
exozymes prices $5.3M public offering at $18 per unit - Investing.com
exozymes prices $5.3M public offering at $18 per unit By Investing.com - Investing.com South Africa
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants - ACCESS Newswire
AI enzyme firm eXoZymes prices $5.33M unit deal with resettable warrants - Stock Titan
eXoZymes (NASDAQ: EXOZ) sells 592,270 shares and 296,135 warrants in $18 units - Stock Titan
EXOZ Technical Analysis | Trend, Signals & Chart Patterns | EXOZYMES INC (NASDAQ:EXOZ) - ChartMill
eXoZymes (EXOZ) seeks to sell units of common stock and warrants in offering - Stock Titan
eXoZymes (EXOZ) to sell share-and-warrant units; MDB holds 47.8% - Stock Titan
eXoZymes Inc. (EXOZ) Surges 5.5% – Key Levels to Watch After the RallyCash Secured Put - newsline.com
eXoZymes Inc. (EXOZ) Climbs 3.13% as Biotech Stock Tests Key Resistance at $10.74Inside Day Breakout - The Legal Advocate
Number of shareholders of eXoZymes Inc. – NASDAQ:EXOZ - TradingView
EXOZYMES INC. 1Q 2026: Revenue $0 Net income $(2.37M) — 10-Q Summary - TradingView
1.17%
2.48%
大文字化:
|
ボリューム (24 時間):